Dr. Jonathan Talamo.
​
NEW BRUNSWICK, N.J.—Johnson & Johnson Vision Care has named Dr. Jonathan Talamo as its new chief medical officer (CMO) and worldwide vice president of medical affairs and clinical affairs for Johnson & Johnson Vision, which comprises both its vision care and surgical businesses.

The move is effective “starting in early July,” the company said in its announcement. Dr. Talamo is an internationally known ophthalmologist with more than 25 years of experience.

“Dr. Talamo is recognized in the eye health community as a leader who is on the cutting edge of innovation,” Peter Shen, global head of R&D for Johnson & Johnson Vision, said in the announcement. “I look forward to working with Dr. Talamo to help our teams in medical and clinical affairs better serve patients.”

Dr. Talamo’s previous post was at Ocular Therapeutix Inc., where he also served as CMO. Prior to Ocular Therapeutix, he owned a private medical practice for almost 20 years, specializing in refractive surgery, cataract surgery and corneal transplantation.

During his career, Dr. Talamo has written more than 80 original peer-reviewed publications, review articles and book chapters and he lectures worldwide on topics related to corneal disease, cataract and refractive surgery, according to J&J’s announcement. He is a recipient of Honor and Senior Achievement awards from the American Academy of Ophthalmology.